» Authors » S H Lowe

S H Lowe

Explore the profile of S H Lowe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 72
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weijsenfeld A, Smit C, Cohen S, Wit F, Mutschelknauss M, van der Knaap L, et al.
Clin Infect Dis . 2016 Jul; 63(8):1105-1112. PMID: 27439528
Background: As a result of effective combination antiretroviral therapy (cART) and advanced supportive healthcare, a growing number of human immunodeficiency virus (HIV)-infected children survive into adulthood. The period of transition...
2.
Rogers K, Conklin R, Lowe S, Petty B
Endocrine . 2010 Dec; 3(11):769-74. PMID: 21153119
Extracellular ionized calcium (Ca(2+)) is the primary physiological regulator of parathyroid hormone (PTH) secretion and the G protein-coupled receptor (CaR) that mediates this response has been cloned from bovine and...
3.
Smeets J, Lowe S, Veraart J
J Eur Acad Dermatol Venereol . 2007 Sep; 21(9):1298-300. PMID: 17894750
No abstract available.
4.
Lowe S, Wensing A, Hassink E, Ten Kate R, Richter C, Schreij G, et al.
HIV Clin Trials . 2005 Nov; 6(5):235-45. PMID: 16306030
Background: To improve the dosing frequency and pill burden of antiretroviral therapy, we compared two once-daily dosed regimens to a twice-daily dosed regimen. Method: HIV-1-infected, antiretroviral drug-naïve adults were randomized...
5.
Lowe S, Prins J, Lange J
Neth J Med . 2005 Feb; 62(11):424-40. PMID: 15685893
The aim of highly active antiretroviral therapy (HAART) for patients chronically infected with the human immunodeficiency virus type I is to achieve maximal and durable viral suppression. Maintaining the blood...
6.
van Leeuwen E, Cornelissen M, de Vries J, Lowe S, Jurriaans S, Repping S, et al.
Hum Reprod . 2004 Sep; 19(12):2845-8. PMID: 15358720
Semen samples from a donor who seroconverted for human immunodeficiency virus type 1 (HIV-1) during the period that he was donating at our clinic were stored before and after infection....
7.
Fox J, Lowe S, Conklin R, Nemeth E
Endocrine . 1999 Aug; 10(2):97-103. PMID: 10451217
NPS R-568 is a Ca2+ receptor agonist ("calcimimetic") compound that reduces circulating parathyroid hormone (PTH) levels in rats and humans with mild secondary hyperparathyroidism (secondary HPT) resulting from chronic renal...
8.
Fox J, Lowe S, Conklin R, Petty B, Nemeth E
J Pharmacol Exp Ther . 1999 Jul; 290(2):480-6. PMID: 10411553
N-(3-[2-Chlorophenyl]propyl)-(R)-alpha-methyl-3-methoxybenzylamine (NPS R-568) is an orally active compound that activates Ca(2+) receptors on parathyroid cells and rapidly suppresses plasma levels of parathyroid hormone (PTH) and Ca(2+) (ED(50), 1 and 10...
9.
Fox J, Lowe S, Petty B, Nemeth E
J Pharmacol Exp Ther . 1999 Jul; 290(2):473-9. PMID: 10411552
Calcimimetics like N-(3-[2-chlorophenyl]propyl)-(R)-alpha-methyl-3-methoxybenzylamine (NPS R-568) potentiate the effects of extracellular Ca(2+) on parathyroid Ca(2+) receptors and inhibit parathyroid hormone (PTH) secretion in vitro. When administered by gavage to normal rats...
10.
Lowe S, Kroon F, Bollemeyer J, Stricker B, van t Wout J
Neth J Med . 1996 Jun; 48(6):211-5. PMID: 8710040
Three patients with a cellular immunodeficiency were treated with rifabutin, clarithromycin and ethambutol for a disseminated infection with Mycobacterium avium-intracellulare complex (MAC). The patients developed uveitis, sometimes in combination with...